Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 17.77 CNY 1.25% Market Closed
Market Cap: 29.7B CNY

Operating Margin

-3.5%
Current
Declining
by 11.8%
vs 3-y average of 8.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.5%
=
Operating Income
¥-211m
/
Revenue
¥6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-3.5%
=
Operating Income
¥-211m
/
Revenue
¥6B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
29.7B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
273.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
Loading...
CH
Novartis AG
SIX:NOVN
218.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Lower than 73% of companies in China
Percentile
27th
Based on 8 544 companies
27th percentile
-3.5%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Shijiazhuang Yiling Pharmaceutical Co Ltd
Glance View

Market Cap
29.7B CNY
Industry
Pharmaceuticals

Shijiazhuang Yiling Pharmaceutical Co Ltd, rooted in the northern heart of China, embodies a harmonious blend of traditional Chinese medicine and modern pharmaceutical science. Born from the insightful vision of Wu Yiling, a prominent figure in integrating traditional Chinese medical practices with contemporary research methodologies, the company has grown into a significant player in the healthcare sector. Its foundation is deeply entrenched in leveraging ancient herbal wisdom while adopting cutting-edge biopharmaceutical technologies. At the core of its operations, Yiling Pharmaceutical specializes in the research, development, and production of therapeutic drugs aimed at treating chronic diseases and boosting immunity. This dual approach allows the company to carve out a niche in producing signature products like Lianhua Qingwen, a respiratory treatment renowned for its efficacy in alleviating symptoms from colds and flu. What powers Yiling Pharmaceutical's continued growth is its steadfast commitment to research and development, translated into a structured pipeline of innovative drugs. The company's funding funnel directs substantial resources into ongoing research, ensuring a constant expansion and refinement of their product portfolio. With an emphasis on effectiveness backed by rigorous scientific validation, Yiling has successfully navigated the complexities of pharmaceutical regulations, extending its reach beyond domestic borders to international markets. This expansionist strategy, coupled with a deep understanding of traditional medicine, forms a robust revenue stream, encapsulating both the domestic market's demand for traditional therapies and the international community's growing interest in alternative medicine solutions. Through these channels, Yiling harmonizes its traditional roots with a forward-thinking business model, ensuring steady financial footholds and promising horizons.

Shijiazhuang Yiling Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-3.5%
=
Operating Income
¥-211m
/
Revenue
¥6B
What is Shijiazhuang Yiling Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for Shijiazhuang Yiling Pharmaceutical Co Ltd is -3.5%, which is below its 3-year median of 8.3%.

How has Operating Margin changed over time?

Over the last 3 years, Shijiazhuang Yiling Pharmaceutical Co Ltd’s Operating Margin has decreased from 19.1% to -3.5%. During this period, it reached a low of -10.9% on Dec 31, 2024 and a high of 26.9% on Mar 31, 2023.

Back to Top